Letter to the editor re: Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment

Ronald L Koretz; Janus Christian Jakobsen; Christian Gluud

doi:10.1136/bmjebm-2018-111072

Letter to the editor re: Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment

Ronald L Koretz, Janus Christian Jakobsen, Christian Gluud

Copenhagen Trial Unit Rigshospitalet

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Evidence-Based Medicine
Vol/bind	23
Udgave nummer	6
Sider (fra-til)	240
ISSN	1356-5524
DOI	https://doi.org/10.1136/bmjebm-2018-111072
Status	Udgivet - 2018

Adgang til dokumentet

10.1136/bmjebm-2018-111072

Citationsformater

Letter to the editor re: Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment. / Koretz, Ronald L; Jakobsen, Janus Christian ; Gluud, Christian.
I: Evidence-Based Medicine, Bind 23, Nr. 6, 2018, s. 240.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

@article{2228037c721441ce90b90bd02dc2f108,

title = "Letter to the editor re: Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment",

author = "Koretz, {Ronald L} and Jakobsen, {Janus Christian} and Christian Gluud",

year = "2018",

doi = "10.1136/bmjebm-2018-111072",

language = "English",

volume = "23",

pages = "240",

journal = "Evidence-Based Medicine",

issn = "1356-5524",

publisher = "B M J Group",

number = "6",

}

TY - JOUR

T1 - Letter to the editor re

T2 - Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment

AU - Koretz, Ronald L

AU - Jakobsen, Janus Christian

AU - Gluud, Christian

PY - 2018

Y1 - 2018

U2 - 10.1136/bmjebm-2018-111072

DO - 10.1136/bmjebm-2018-111072

M3 - Comment/debate

C2 - 30171020

SN - 1356-5524

VL - 23

SP - 240

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

IS - 6

ER -